Digital healthcare company Citiustech has reportedly confidentially filed to hold a US initial public offering as early as this year.

Citiustech, which provides technology and consulting services to healthcare and life sciences companies, is also considering a sale if it is unable to conduct an IPO due to market conditions. The company could carry a valuation of more than $2B, according to a Bloomberg report.

In March, Bloomberg reported that Citiustech was exploring going public through a SPAC deal that would have valued the company at around $1B. Hong Kong-based Barings Private Equity Asia, or BPEA, holds a majority stake in Citiustech.

Earlier this...